Quantcast Alnylam Pharmaceut Stock Quote | Stock Price for ALNY | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alnylam Pharmaceut (NQ: ALNY)
67.54 USD  -1.19 (-1.73%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 815,400
Open 67.91
Bid (Size) 67.25 (4)
Ask (Size) 70.00 (1)
Prev. Close 68.73
Today's Range 67.33 - 69.25
52wk Range 60.27 - 122.86
Shares Outstanding 100,522,411
Dividend Yield N/A
Performance
YTD
-7.17%
-7.17%
1 Month
-17.70%
-17.70%
3 Month
-15.97%
-15.97%
6 Month
-5.51%
-5.51%
1 Year
-34.31%
-34.31%
Top News
More News
Alnylam to Webcast Presentation at Bank of America Merrill Lynch Health Care Conference 2019
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Bank of America Merrill Lynch Health Care... Read More
from Business Wire News Releases
Life Science Cares Announces Inaugural Group of Founding Corporate Members
Twenty-seven life science companies have signed on as Founding Members of Life Science Cares, a non-profit collective effort of the Life Science industry to eliminate the impact of poverty in the... Read More
from Business Wire News Releases
More News
Read More
Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity
from Business Wire News Releases
Noteworthy Friday Option Activity: ALNY, CYRX, AKCA
category Stocks
from Market News Video
Alnylam Highlights Progress on Global Market Access for ONPATTRO (patisiran)
from Business Wire News Releases
Downtrend Call Working As Alnylam Pharmace Stock Falls 18.4% (ALNY)
from Comtex SmarTrend® News Briefs
This Dow Jones Pharma Giant Is Now A 'Top Pick' — Here's Why
from Investor's Business Daily
UPDATE 2-Pfizer gets U.S. approval for $225,000 a year heart drug
category companyNews
from Reuters: Company News
UPDATE 1-Pfizer gets U.S. approval for $225,000 a year heart drug
category companyNews
from Reuters: Company News
Noteworthy Friday Option Activity: WPG, ALNY, JOE
category Stocks
from Market News Video
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
category Market News , EIDX , AKCA , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.